ISPC vs XRAY · rev $9.3M vs rev $3.68B
iSpecimen Inc (ISPC) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
ISPC currently screens at market cap $4.4M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the ISPC and XRAY stock pages for the full models.
Not investment advice.